Conviction in engineering services, skepticism about certain small-cap names
In the quiet arithmetic of quarterly disclosures, veteran investor Mukul Agrawal has revealed the contours of a portfolio in deliberate motion — expanding into 71 holdings worth over Rs 7,498 crore while simultaneously retreating from positions that no longer serve his thesis. His near-doubling of stake in ASM Technologies, alongside fresh entries into recently listed and sector-specific companies, speaks to the ancient investor's discipline of knowing not just what to hold, but what to release. The rebalancing is less a story of individual stocks than a philosophical statement about where one seasoned mind believes value is being created in India's industrial and technological landscape.
- Agrawal's stake in ASM Technologies surged from 6.5% to 10.7% in a single quarter, a concentrated bet now worth over Rs 500 crore that signals deep conviction in engineering services.
- Ten new companies entered his portfolio simultaneously, spanning appliances, government technology, green energy, and electric mobility — a wide net cast with deliberate precision.
- Stakes in Sula Vineyards and BSE have slipped below the 1% public disclosure threshold, leaving markets uncertain whether he has exited or simply faded from view.
- Several small-cap holdings — including Sirca Paints, Stanley Lifestyles, and Oriental Rail Infrastructure — were trimmed, suggesting a recalibration away from names that no longer fit his evolving thesis.
- His top five positions remain anchored in established businesses like Neuland Laboratories and Radico Khaitan, balancing the speculative energy of new additions with the gravity of proven enterprises.
Mukul Agrawal, a veteran investor whose quarterly disclosures function almost as market signals in themselves, has reshaped his portfolio in ways that reveal both ambition and discipline. Tracking data from Trendlyne shows he now holds stakes in 71 listed Indian companies, with a combined value exceeding Rs 7,498.5 crore — the result of a quarter defined by simultaneous expansion and pruning.
The headline move is his deepening commitment to ASM Technologies, where his stake climbed from 6.5% to 10.7% between June and September. That single position is now worth more than Rs 500 crore. The company — which provides engineering services, product R&D, and equipment manufacturing — represents the kind of industrial backbone play that rewards patient capital.
Beyond ASM, Agrawal added ten entirely new companies to his holdings: IFB Industries, Protean eGov Technologies, Kilitch Drugs, NR Agarwal Industries, Solarium Green Energy, Unified Data Tech Solutions, Zelio EMobility, and two recently listed firms — Vikran Engineering and Laxmi Finance. None are household names, but each represents a calculated entry at a specific moment.
His largest positions remain grounded in established businesses: Neuland Laboratories leads at over Rs 600 crore, followed by ASM Technologies, Radico Khaitan, Zota Healthcare, and Nuvama Wealth. These are not speculative bets — they reflect sustained conviction in particular sectors and management teams.
On the other side of the ledger, Agrawal reduced his exposure to several small-cap names and allowed his stakes in Sula Vineyards and BSE to fall below the 1% public disclosure threshold. Whether those represent full exits or quiet drift remains unclear. What is clear is the direction: a portfolio actively redeploying capital toward engineering, technology, and select new listings, while stepping back from positions that no longer earn their place.
Mukul Agrawal, a veteran investor whose moves are closely watched by market participants, has been busy reshaping his portfolio. According to data from Trendlyne, an analytics firm that tracks shareholding patterns, Agrawal now holds stakes in 71 publicly listed companies across Indian markets, with a combined portfolio value exceeding Rs 7,498.5 crore. The activity reflects a deliberate rebalancing—adding new positions while trimming others, a signal of where he sees opportunity and where he sees risk.
The most visible move has been his deepening commitment to ASM Technologies. In just three months, from June to September, his stake in the engineering services and product development company nearly doubled, climbing from 6.5 percent to 10.7 percent. At current market prices, this position alone is worth more than Rs 500 crore. The company provides engineering services, conducts product research and development, and manufactures equipment—the kind of industrial backbone play that tends to appeal to investors with a long-term view.
Across the quarter, Agrawal added ten entirely new companies to his holdings. The list reads like a deliberate sweep across different sectors: IFB Industries, the appliance manufacturer; Protean eGov Technologies, which works in government technology solutions; Kilitch Drugs; NR Agarwal Industries; Solarium Green Energy; Unified Data Tech Solutions; and Zelio EMobility. He also picked up stakes in two recently listed companies—Vikran Engineering at roughly 1.2 percent and Laxmi Finance at 3.8 percent. These are not household names, but they represent calculated bets on specific businesses at specific moments.
His largest holdings tell a different story. As of September, his top five positions were Neuland Laboratories, valued at over Rs 600 crore; ASM Technologies; Radico Khaitan, the spirits company, at over Rs 400 crore; Zota Healthcare at nearly Rs 400 crore; and Nuvama Wealth at nearly Rs 370 crore. These are established businesses with track records, not speculative plays. The concentration suggests conviction in specific sectors and management teams.
At the same time, Agrawal has been pruning. His stakes in several small-cap stocks declined during the quarter—Sirca Paints, PDS, Stanley Lifestyles, and Oriental Rail Infrastructure all saw reduced holdings. More notably, his positions in Sula Vineyards and BSE have fallen below the one percent threshold at which shareholding must be publicly disclosed. Whether he has exited these positions entirely or simply allowed his stake to drift below the reporting line remains unclear from the data alone. Either way, the direction is the same: less exposure to these names.
The pattern suggests a portfolio in motion. Agrawal is not simply holding and waiting. He is actively deploying capital into new opportunities, significantly increasing his bet on ASM Technologies, and stepping back from smaller positions that no longer fit his thesis. For investors who track his moves as a barometer of where sophisticated capital is flowing, the message is clear: there is conviction in engineering services and technology plays, skepticism about certain small-cap names, and a willingness to take meaningful stakes when the opportunity warrants it.
Citações Notáveis
ASM Technologies provides engineering services, product R&D, and consulting, and is an equipment manufacturer— Trendlyne portfolio data
A Conversa do Hearth Outra perspectiva sobre a história
Why would an investor with Rs 7,500 crore suddenly add ten new stocks to a portfolio that already holds 71? That seems like spreading himself thin.
It's not about quantity—it's about finding the right fit at the right price. When you have that much capital, you're constantly scanning for opportunities. Ten new positions across a quarter is actually disciplined, not scattered.
But ASM Technologies is the real story here, isn't it? He nearly doubled his stake in three months. That's not passive.
Exactly. That's conviction. He went from 6.5 to 10.7 percent. At that level, you're signaling serious belief in the company's direction. It's not a trade—it's a position.
What does that tell you about where he sees value right now?
Engineering services, product development, industrial infrastructure. These are not sexy sectors, but they're foundational. And in a market that swings between momentum and fundamentals, he's clearly betting on fundamentals.
He's also exiting things—Sula Vineyards, BSE, smaller caps. Is he just getting out of trouble?
Or he's being selective. The small-caps he's trimming probably stopped meeting his criteria. That's not panic—that's discipline. You don't hold something just because you bought it once.
So what's the read? Is he bullish or cautious?
Both. He's adding where he sees real business value, but he's not chasing. He's trimming where the thesis has weakened. That's the posture of someone who's been through cycles and knows the difference between a good company and a good price.